|
|
Blood, 15 April 2005, Vol. 105, No. 8, pp. 3356-3364.
Prepublished online as a Blood First Edition Paper on December 21, 2004; DOI 10.1182/blood-2004-08-3080.
Previous Article | Next Article 
Submitted August 9, 2004
Accepted November 4, 2004
Determinants of ABH expression on human blood platelets
Laura L Cooling*, Kathleen Kelly, James Barton, Debbie Hwang, Theodore A Koerner, and John D Olson
Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Pathology, University of Iowa, Iowa City, IA, USA
Department of Pathology, University of Iowa, Iowa City, IA, USA
Department of Pathology, University of Michigan, Ann Arbor, MI, USA
* Corresponding author; email: lcooling{at}med.umich.edu.
Platelets express ABH antigens, which can adversely effect platelet transfusion recovery and survival in ABH-incompatible recipients. To date, there has been no large, comprehensive study comparing specific donor factors with ABH expression on platelet membranes and glycoconjugates. We studied ABH expression in 166 group A apheresis platelet donors by flow cytometry, western blotting and thin layer chromatography relative to donor age, sex, A1/A2 subgroup and Lewis phenotype. Overall, A antigen on platelet membranes, glycoproteins and glycosphingolipids was linked to an A1 RBC phenotype. Among A1 donors, platelet ABH varied significantly between donors (0-87%). Intra-donor variability, however, was minimal, suggesting that platelet ABH expression is a stable, donor-specific characteristic, with 5% of A1 donors typing as ABH high- and low-expressers, respectively. Group A2 donors, in contrast, possessed a Bombay-like phenotype, lacking both A and H antigens. Unlike RBC, ABH expression on platelets may be determined primarily by H-glycosyltransferase (FUT1) activity. Identification of A2 and A1 low expressers may increase the availability and selection of crossmatched and HLA-matched platelets. Platelets from group A2 may also be a superior product for patients undergoing A/O major mismatch allogeneic progenitor cell transplantation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Universal platelets: "A" change in dogma
- David Stroncek
Blood 2005 105: 3008.
[Full Text]
[PDF]
Related Letter in Blood Online:
-
Expression of ABH antigens on platelets
- Brian R. Curtis, Richard H. Aster, and Laura L. Cooling
Blood 2006 107: 842-843.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
F. Kimura, K. Sato, S. Kobayashi, T. Ikeda, H. Sao, S. Okamoto, K. Miyamura, S. Mori, H. Akiyama, M. Hirokawa, et al.
Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program
Haematologica,
November 1, 2008;
93(11):
1686 - 1693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Klumpp and D. L. Siegel
Transfusion medicine
ASH Self-Assessment Program,
January 1, 2007;
2007(1):
408 - 443.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nambiar, R. J. Duquesnoy, S. Adams, Y. Zhao, J. Oblitas, S. Leitman, D. Stroncek, and F. Marincola
HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients
Blood,
February 15, 2006;
107(4):
1680 - 1687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Curtis, R. H. Aster, and L. L. Cooling
Expression of ABH antigens on platelets
Blood,
January 15, 2006;
107(2):
842 - 843.
[Full Text]
[PDF]
|
 |
|
|
|